Biol Reprod
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


BOR - Papers in Press, published online ahead of print May 12, 2004.
Biol Reprod 2004, 10.1095/biolreprod.104.028936
This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
71/3/813    most recent
biolreprod.104.028936v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Van Vugt, H. H.
Right arrow Articles by Van der Beek, E. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Van Vugt, H. H.
Right arrow Articles by Van der Beek, E. M.
Agricola
Right arrow Articles by Van Vugt, H. H.
Right arrow Articles by Van der Beek, E. M.
Submitted March 9, 2004
Returned for revision March 28, 2004
Accepted May 6, 2004

Neuroendocrinology


Centrally Applied Somatostatin Inhibits the Estrogen-Induced Luteinizing Hormone Surge via Hypothalamic Gonadotropin-Releasing Hormone Cell Activation in Female Rats

Harmke H. Van Vugt *, Hans J.M. Swarts , Bert J.M. Van de Heijning , and Eline M. Van der Beek

* To whom correspondence should be addressed. E-mail: harmke.vanvugt{at}wur.nl.

Abstract
Overexpression of growth hormone (GH) as well as GH-deficiency dramatically impairs reproductive function. Decreased reproductive function as a result of altered GH release is, at least partially, due to changes at the hypothalamic-pituitary level. We hypothesize that hypothalamic somatostatin (SOM), the inhibiting factor of GH release from the pituitary, may play a central role in the "crosstalk" between the somatotropic and gonadotropic axis. In the present study we investigated the possible effects of a centrally applied SOM analog on the LH surge and the concurrent activation of hypothalamic GnRH neurons in female rats. To this end, female rats were treated with estradiol 2 weeks after ovariectomy and were given a single central injection with either the SOM analog octreotide or saline just prior to surge onset, after which hourly blood samples were taken to measure LH. Two weeks later, the experimental setup was randomly repeated to collect brains during the anticipated ascending phase of the LH surge. Vibratome sections were subsequently double stained for GnRH and cFos peptide. Following octreotide treatment, LH surges were significantly attenuated compared to those in saline-treated control females. Also, octreotide treatment significantly decreased the activation of hypothalamic GnRH neurons. These results clearly demonstrate that SOM is able to inhibit LH release, at least in part by decreasing the activation of GnRH neurons. Based on these results, we hypothesize that hypothalamic SOM may be critically involved in the physiological regulation of the proestrus LH surge.

Key words: Gonadotropin-releasing hormone • Growth hormone • Hypothalamus • Luteinizing hormone • Ovulatory cycle


This article has been cited by other articles:


Home page
ReproductionHome page
J. Robinson
Prenatal programming of the female reproductive neuroendocrine system by androgens.
Reproduction, October 1, 2006; 132(4): 539 - 547.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2004 by the Society for the Study of Reproduction.